Why attend?

Why attend ECB2026?

ECB2026 offers a unique opportunity to be part of one of Europe’s most established and influential biotechnology congresses. Building on the strong legacy of previous editions, including ECB2024 link to the previous edition, the congress brings together the global biotechnology community to address current scientific advances and future challenges across health, food security, sustainability, and industrial innovation.

By attending ECB2026, you will:

Be inspired by leading voices in biotechnology

Engage with plenary and keynote lectures delivered by internationally renowned speakers shaping the future of biotechnology.

Connect with world-class experts

Meet invited speakers and thought leaders from academia and industry, representing diverse sectors and perspectives.

Showcase your research

Present your scientific results to a highly relevant audience through posters, flash presentations, or short talks selected from submitted abstracts.

Gain a global and European perspective

Explore the latest research trends, technological breakthroughs, and policy-relevant developments in biotechnology across Europe and worldwide.

Strengthen the voice of biotechnology in Europe

Engage with the European Federation of Biotechnology (EFB) and become part of a vibrant, interdisciplinary community.

Take part in highlight and satellite events

Join focused sessions addressing emerging challenges, controversies, and opportunities, alongside dedicated satellite

Explore innovation at the trade exhibition

Discover cutting-edge products, technologies, and services from leading biotech companies and organisations.

Expand your professional network

Network with hundreds of biotechnologists from academia and industry, from across Europe and beyond.

Support early-career development

Benefit from dedicated workshops, including publication-focused sessions designed to help young biotechnologists publish in leading journals.

ECB2026 is the place to exchange ideas, build collaborations, and help shape the future of biotechnology.